Intramolecular charge transfer endows near-infrared mitochondrial targeted photosensitizers with enhanced photodynamic therapy
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2026-12 · 363 · 128351
DOI: 10.1016/j.saa.2026.128351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2026-12. Verfasst von Yurong Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological and Chemical Engineering, Qilu Institute of Technology, Jinan 250200, China. Electronic address: qlgyr@qlit.edu.cn. Hauptthemen laut MEDLINE: Photochemotherapy, Photosensitizing Agents, Mitochondria. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Fluorescence-imaging guided photodynamic therapy (FLI-PDT) has been enhanced by the rapid development of luminogens with AIE characteristics (AIEgens), which possess dual functions of imaging and PDT capabilities. Here, we provide a reformulated AIEgens, named TTPE, by enhancing the intramolecular charge-transfer ability with theoretical guidance. TTPE was empowered with extended coplanar conjugation and strengthened electron donor-acceptor (D-A) intensity, resulting in redshifted near-infrared emission as well as improved singlet oxygen (1O₂) yield. TTPE was used to visualize the differences in ROS and 1O₂ dynamics by tracking the instantaneous flow over time and depicting mitochondrial morphological changes in LPS-stimulated H9C2 cells. Given its selectivity for cancer cells over normal cells, the PDT efficacy of TTPE was evaluated using both CCK-8 and cytometry analyses. Results show that TTPE achieved remarkable PDT efficiency against LM3 cells compared to normal LO2 cells, using a portable white flashlight (700 mW/cm2). In summary, TTPE would work as a promising theragnostic system to fight against cancer, and the design strategy would shed light on other systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biological and Chemical Engineering, Qilu Institute of Technology, Jinan 250200, China. Electronic address: qlgyr@qlit.edu.cn.
- State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences (CAS), 116023, China.
- College of Biological and Chemical Engineering, Qilu Institute of Technology, Jinan 250200, China.
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli Chaoyan…
- State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences (CAS), 116023, China. Electronic address: jiayan@dicp.ac.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, Y., Wang, Y., Li, J., Han, S., Yu, L., Li, F., Yang, S., Gao, X., Wang, Z., Wang, X., & Jia, Y. (2026). Intramolecular charge transfer endows near-infrared mitochondrial targeted photosensitizers with enhanced photodynamic therapy. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 363, 128351. https://doi.org/10.1016/j.saa.2026.128351
Vancouver
Guo Y, Wang Y, Li J, Han S, Yu L, Li F, et al. Intramolecular charge transfer endows near-infrared mitochondrial targeted photosensitizers with enhanced photodynamic therapy. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2026;363:128351. doi:10.1016/j.saa.2026.128351
BibTeX
@article{Guo2026,
author = {Guo, Yurong and Wang, Yiying and Li, Jiali and Han, Suqin and Yu, Lei and Li, Feng and Yang, Shengbiao and Gao, Xing and Wang, Zhao and Wang, Xin and Jia, Yan},
title = {Intramolecular charge transfer endows near-infrared mitochondrial targeted photosensitizers with enhanced photodynamic therapy},
journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
year = {2026},
volume = {363},
pages = {128351},
doi = {10.1016/j.saa.2026.128351}
}
EUVIMED